AstraZeneca had hoped to pitch its Iressa drug against rival medicine Tarceva. AstraZeneca hit by drug failureShares in Anglo-Swedish drug have closed down 8% in UK trade after the failure of its Iressa drug in a major clinical trial. The company said Mr Patterson would make "substantial changes to the clinical organisation and its processes". Tarceva - made by OSI Pharmaceuticals, Genentech and Roche - has already proved to be successful in helping prolong the life of lung cancer patients. The lung cancer drug did not significantly prolong survival in patients with the disease.